14-6-8　ⓔ文献

  1. Saraf P, Berger HW, et al: Goodpasture’s syndrome with no overt renal disease. Mt Sinai J Med, 1978; 45: 451–454.

  2. Saus J, Wieslander J, et al: Identification of the Goodpasture antigen as the alpha 3 (IV) chain of collagen IV. J Biol Chem, 1988; 263: 13374–13380.

  3. Fischer EG, Lager DJ: Anti–glomerular basement membrane glomerulonephritis: a morphologic study of 80 cases. Am J Clin Pathol, 2006; 125: 445–450.

  4. 厚生労働省特定疾患進行性腎障害に関する調査研究班：急速進行性腎炎症候群の診療指針　第2版．日本腎臓学会誌，2011; 53: 509–555.

  5. Hirayama K, Yamagata K, eds: Anti–glomerular basement membrane disease. An Update of Glomerulopathies–Clinical and Treatment Aspects (Prabhakar SS ed), INTECH, 2011.

  6. Levy JB, Hammad T, et al: Clinical features and outcome of patients with both ANCA and anti–GBM antibodies. Kidney Int, 2004; 66: 1535–1540.

  7. Vanacore RM, Ham AJ, et al: A role for collagen IV cross–links in conferring immune privilege to the Goodpasture autoantigen: structural basis for the crypticity of B cell epitopes. J Biol Chem, 2008; 283: 22737–22748.

  8. Wilson CB, Dixon F: Anti–glomerular basement membrane antibody–induced glomerulonephritis. Kid Int, 1973; 3: 74–89.

  9. Bombassei GJ, Kaplan AA: The association between hydrocarbon exposure and anti–glomerular basement membrane antibody–mediated disease (Goodpasture’s syndrome). Am J Ind Med, 1992; 21: 141–153.

  10. Kleinknecht D, Morel–Maroger L, et al: Antiglomerular basement membrane nephritis after solvent exposure. Arch Intern Med, 1980; 140: 230–232.

  11. Taylor DM, Yehia M, et al: Anti–glomerular basement membrane disease in Auckland. Intern Med J, 2012; 42: 672–676.

  12. Iwamoto I, Yonekawa S, et al: Anti–glomerular basement membrane nephritis after extracorporeal shock wave lithotripsy. Am J Nephrol, 1998; 18: 534–537.

  13. Ooi J D, Petersen J, et al: Dominant protection from HLA–linked autoimmunity by antigen–specific regulatory T cells. Nature, 2017; 545: 243–247.

  14. Nakamura A, Yuasa T, et al: Fcgamma receptor IIB–deficient mice develop Goodpasture’s syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease. J Exp Med, 2000; 191: 899–906.

  15. Wu J, Borillo J, et al: T–cell epitope of alpha3 chain of type IV collagen induces severe glomerulonephritis. Kidney Int, 2003; 64: 1292–1301.

  16. Ferrario F, Tadros MT, et al: Critical re–evaluation of 41 cases of idiopathic crescentic glomerulonephritis. Clin Nephrol, 1994; 41: 1–9.